Intracranial Hypertension in Acute Liver Failure: Pathophysiological Basis of Rational Management

 

 Buy Article Permissions and Reprints

ABSTRACT

Increased intracranial pressure (ICP) in patients with acute liver failure (ALF) remains a major cause of morbidity and mortality. Conventional methods of ammonia reduction such as the use of lactulose do not improve outcome, and metabolic substrates such as L-ornithine L aspartate may offer more promise. Mannitol remains the mainstay of therapy. An important role for cerebral hyperemia in the pathogenesis of increased ICP has led to a reevaluation of established therapies such as hyperventilation, N-acetylcysteine, thiopentone sodium, and propofol. Recent studies have focused on the role of systemic inflammatory response in the pathogenesis of increased ICP and support the use of antibiotics prophylactically. Moderate hypothermia reduces ICP in patients with uncontrolled intracranial hypertension and prevents increases in ICP during orthotopic liver transplantation (OLT). Advances in understanding the pathophysiological basis of intracranial hypertension in ALF have outstripped appropriate testing of the newly generated ideas in appropriate clinical trials, and more effort should be mounted at a national level to organize the appropriate multicenter studies required.

REFERENCES

• 1 Trey C, Davidson C S. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in Liver Disease, Vol III. New York: Grune and Stratton 1970: 282-298
  Google Scholar
• 2 O'Grady J G, Alexander G JM, Hayllar K M, Williams R. Early indicators of prognosis in fulminant hepatic failure.  Gastroenterology . 1989;  97 439-445
  PubMedGoogle Scholar
• 3 Ascher N L, Lake J R, Emond J C, Roberts J P. Liver transplantation for fulminant hepatic failure.  Arch Surg . 1993;  128 677-682
  PubMedGoogle Scholar
• 4 Makin A J, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993).  Gastroenterology . 1995;  109 1907-1916
  CrossrefPubMedGoogle Scholar
• 5 Hoofnagle J H, Carithers R L, Chapiro C, Ascher N L. Fulminant hepatic failure: summary of a workshop.  Hepatology . 1995;  21 240-252
  CrossrefPubMedGoogle Scholar
• 6 Norenberg M D. Astroglial dysfunction in hepatic encephalopathy.  Metab Brain Dis . 1998;  13 319-335
  CrossrefPubMedGoogle Scholar
• 7 Butterworth R. Molecular neurobiology of acute liver failure.  Semin Liver Dis . 2003;  23 251-258
  Article in Thieme ConnectPubMedGoogle Scholar
• 8 Vaquero J, Chung C, Cahill M E, Blei A T. Pathogenesis of hepatic encephalopathy in acute liver failure.  Semin Liver Dis . 2003;  23 259-270
  Article in Thieme ConnectPubMedGoogle Scholar
• 9 Larsen F S, Wendon J. Brain edema in liver failure: basic physiologic principles and management.  Liver Transplantation . 2002;  8 983-989
  CrossrefPubMedGoogle Scholar
• 10 Blei A T, Larsen F S. Pathophysiology of cerebral edema in fulminant hepatic failure.  J Hepatol . 1999;  31 771-776
  CrossrefPubMedGoogle Scholar
• 11 Bihari D J, Gimson A E, Williams R. Cardiovascular, pulmonary and renal complications of fulminant hepatic failure.  Semin Liver Dis . 1986;  6 119-128
  PubMedGoogle Scholar
• 12 Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom.  Semin Liver Dis . 2003;  23 000
  PubMedGoogle Scholar
• 13 Conn H O, Leevy C M, Vlahcevic Z R. et al . Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.  Gastroenterology . 1977;  72 573-583
  PubMedGoogle Scholar
• 14 Vaquero J, Oliver D, Hassanein T. et al .Evaluation of mental state in a clinical trial of MARS for patients with acute hepatic encephalopathy: comparison of two scales. In: Chamuleau R, Jones A, Meijers A, eds. 11th International Symposium on Hepatic Encephalopathy and Ammonia Metabolism 2003; 55-70
  Google Scholar
• 15 Wijdicks E FM, Nyberg S L. Propofol to control intracranial pressure in fulminant hepatic failure.  Transplant Proc . 2002;  34 1220-1222
  CrossrefPubMedGoogle Scholar
• 16 Cordoba J, Blei A T. Cerebral edema and intracranial pressure monitoring.  Liver Transplantation Surg . 1995;  1 187-194
  PubMedGoogle Scholar
• 17 Kanazi G, Plevak D, Rakela J. et al . How helpful is intracranial pressure monitoring in patients with acute hepatic failure?.  Transplant Proc . 1993;  25 1819
  PubMedGoogle Scholar
• 18 Blei A T, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure.  Lancet . 1993;  341 157-158
  CrossrefPubMedGoogle Scholar
• 19 Daas M, Plevak D J, Wijdicks E F. et al . Acute liver failure: results of a 5-year clinical protocol.  Liver Transplantation Surg . 1995;  1 210-219
  PubMedGoogle Scholar
• 20 Lidofsky S D, Bass N M, Prager M C. et al . Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure.  Hepatology . 1992;  16 1-7
  PubMedGoogle Scholar
• 21 Shami V M, Caldwell S H, Hespenheide E E. et al . Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.  Liver Transplantation . 2003;  9 138-143
  CrossrefPubMedGoogle Scholar
• 22 White H, Baker A. Continuous jugular venous oximetry in the neurointensive care unit-a brief review.  Can J Anaesth . 2002;  49 623-629
  PubMedGoogle Scholar
• 23 Larsen F S, Hansen B A, Ejlersen E. et al . Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure.  Eur J Gastroenterol Hepatol . 1996;  8 261-265
  CrossrefPubMedGoogle Scholar
• 24 Ellis A J, Wendon J A, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial.  Hepatology . 2000;  32 536-541
  CrossrefPubMedGoogle Scholar
• 25 Nielsen H B, Tofteng F, Wang L P, Larsen F S. Cerebral oxygenation determined by near-infrared spectrophotometry in patients with fulminant hepatic failure.  J Hepatol . 2003;  38 188-192
  PubMedGoogle Scholar
• 26 Tofteng F, Jorgensen L, Hansen B A. et al . Cerebral microdialysis in patients with fulminant hepatic failure.  Hepatology . 2002;  36 1333-1340
  CrossrefPubMedGoogle Scholar
• 27 Cordoba J, Alonso J, Rovira A. et al . The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation.  J Hepatol . 2001;  35 598-604
  CrossrefPubMedGoogle Scholar
• 28 Clemmesen J O, Larsen F S, Kondrup J. et al . Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration.  Hepatology . 1999;  29 648-653
  CrossrefPubMedGoogle Scholar
• 29 McCashland T M, Shaw B W, Tape E. The American experience with transplantation for acute liver failure.  Semin Liver Dis . 1996;  16 427-433
  Article in Thieme ConnectPubMedGoogle Scholar
• 30 Davies M H, Mutimer D, Lowes J. et al . Recovery despite impaired cerebral perfusion in fulminant hepatic failure.  Lancet . 1994;  343 1329-1330
  CrossrefPubMedGoogle Scholar
• 31 Blei A T, Olafsson S, Therrien G, Butterworth R F. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis.  Hepatology . 1994;  19 1437-1444
  CrossrefPubMedGoogle Scholar
• 32 Larsen F S. Cerebral circulation in liver failure: Ohm's law in force.  Semin Liver Dis . 1996;  16 281-292
  PubMedGoogle Scholar
• 33 Rolando N, Wade J, Davalos M. et al . The systemic inflammatory response syndrome in acute liver failure Hepatology .  2000;  32 734-739
  CrossrefPubMedGoogle Scholar
• 34 Jalan R, Pollok A, Shah S. et al . Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure.  J Hepatol . 2002;  37 536
  CrossrefPubMedGoogle Scholar
• 35 Jalan R, Williams R. The inflammatory basis of intracranial hypertension in acute liver failure.  J Hepatol . 2001;  34 940-942
  CrossrefPubMedGoogle Scholar
• 36 Lai J C, Cooper A J. Brain alpha-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors.  J Neurochem . 1986;  47 1376-1386
  CrossrefPubMedGoogle Scholar
• 37 Michalak A, Rose C, Butterworth J, Butterworth R F. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure.  Hepatology . 1996;  24 908-913
  PubMedGoogle Scholar
• 38 Zwingmann C, Chatauret N, Leibfritz D, Butterworth R F. Selective increase of brain lactate synthesis in experimental acute liver failure: Results of a [¹H-¹³C] nuclear magnetic resonance study.  Hepatology . 2003;  37 420-428
  CrossrefPubMedGoogle Scholar
• 39 Chung C, Gottstein J, Vaquero J. et al . Vasopressin infusion accelerates the development of brain edema in rats after portacaval anastomosis.  Hepatology . 2002;  36 380A
  PubMedGoogle Scholar
• 40 Shawcross D, Davies N A, Hayes P C. et al . Worsening of cerebral hyperemia with Terlipressin in acute liver failure.  Gut . 2003;  52 (suppl 1) A2
  PubMedGoogle Scholar
• 41 Munoz S J, Moritz M J, Bell R. et al . Factors associated with severe intracranial hypertension in candidates for emergency liver transplantation.  Transplantation . 1993;  55 1071-1074
  PubMedGoogle Scholar
• 42 Kodakar S K, Gopal P B, Wendon J A. Intracranial pressure is related to body temperature in acute liver failure.  Liver Transplantation . 2001;  7 C87
  CrossrefPubMedGoogle Scholar
• 43 Kodakar S K, Gopal P B, Wendon J A. Hyperglycemia is associated with intracranial hypertension in patients with acute liver failure.  Liver Transplantation . 2001;  7 C21
  PubMedGoogle Scholar
• 44 Cordoba J, Gottstein J, Blei A T. Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis.  J Hepatol . 1998;  29 589-594
  CrossrefPubMedGoogle Scholar
• 45 Jalan R, Dabos K, Redhead D N. et al . Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.  J Hepatol . 1997;  27 928-933
  CrossrefPubMedGoogle Scholar
• 46 van Hulst A R, Hasan D, Lachmann B. Intracranial pressure, brain PCO2, PO2, and pH during hypo- and hyperventilation at constant mean airway pressure in pigs.  Intensive Care Med . 2002;  28 68-73
  CrossrefPubMedGoogle Scholar
• 47 Winney R J, Kean D M, Best J J, Smith M A. Changes in brain water with haemodialysis.  Lancet . 1986;  8(2) 1107-1108
  PubMedGoogle Scholar
• 48 Alba L, Hay J E, Angulo P, Lee W M. Lactulose therapy in acute liver failure (Abst).  J Hepatol . 2002;  36(Suppl 1) 33
  PubMedGoogle Scholar
• 49 Kircheis G, Nilius R, Held C. et al . Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.  Hepatology . 1997;  25 1351-1360
  CrossrefPubMedGoogle Scholar
• 50 Rose C, Michalak A, Rao K V. et al . L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.  Hepatology . 1999;  30 636-640
  CrossrefPubMedGoogle Scholar
• 51 Master S, Gottstein J, Blei A T. Cerebral blood flow and the development of ammonia-induced brain edema in rats after portacaval anastomosis.  Hepatology . 1999;  30 876-880
  CrossrefPubMedGoogle Scholar
• 52 Canalese J, Gimson A ES, Davis C. et al . Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure.  Gut . 1982;  23 625-629
  PubMedGoogle Scholar
• 53 Vogels B A, Maas M A, Daalhuisen J. et al . Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.  Hepatology . 1997;  25 820-877
  CrossrefPubMedGoogle Scholar
• 54 Strauss G, Hansen B A, Knudsen G M, Larsen F S. Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure.  J Hepatol . 1998;  28 199-203
  PubMedGoogle Scholar
• 55 Ede R J, Gimson A E, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure.  J Hepatol . 1986;  2 43-51
  CrossrefPubMedGoogle Scholar
• 56 Jones A L, Bangash I H, Bouchier I A, Hayes P C. Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis.  Gut . 1994;  35 1290-1293
  PubMedGoogle Scholar
• 57 Harrison P M, Keays R, Bray G P. et al . Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine.  Lancet . 1990;  30 335:1572-1573
  PubMedGoogle Scholar
• 58 Keays R, Harrison P M, Wendon J A. et al . Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial.  BMJ . 1991;  303 1026-1029
  PubMedGoogle Scholar
• 59 Harrison P M, Wendon J A, Gimson A E. et al . Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure.  N Engl J Med . 1991;  324 1852-1857
  PubMedGoogle Scholar
• 60 Walsh T S, Hopton P, Philips B J. et al . The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure.  Hepatology . 1998;  27 1332-1340
  CrossrefPubMedGoogle Scholar
• 61 Forbes A, Alexander G J, O'Grady J G. et al . Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure.  Hepatology . 1989;  10 306-310
  PubMedGoogle Scholar
• 62 Jensen K, Ohrstrom J, Cold G E, Astrup J. Indomethacin (Confortid) in severe head injury and elevated intracranial pressure (ICP).  Acta Neurochir Suppl (Wien) . 1992;  55 47-48
  PubMedGoogle Scholar
• 63 Clemmesen J O, Hansen B A, Larsen F S. Indomethacin normalizes intracranial pressure in acute liver failure: a twenty-three-year-old woman treated with indomethacin.  Hepatology . 1997;  26 1423-1425
  PubMedGoogle Scholar
• 64 Chung C, Gottstein J, Blei A T. Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis.  Hepatology . 2001;  34 249-254
  CrossrefPubMedGoogle Scholar
• 65 Ringe B, Lubbe N, Kuse E. et al . Total hepatectomy and liver transplantation as two-stage procedure.  Ann Surg . 1993;  218 3-9
  CrossrefPubMedGoogle Scholar
• 66 Rolando N, Gimson A, Wade J. et al . Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure.  Hepatology . 1993;  17 196-201
  CrossrefPubMedGoogle Scholar
• 67 Peignoux M, Bernuau J, Benhamou J P. Total hepatectomy and vascular exclusion in the rat. A comparison, with special reference to the influence of body temperature.  Clin Sci . 1982;  62 273-277
  PubMedGoogle Scholar
• 68 Eguchi S, Kamlot A, Ljubimova J. et al . Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration.  Hepatology . 1996;  24 1452-1459
  PubMedGoogle Scholar
• 69 Traber P, DalCanto M, Ganger D, Blei A T. Effect of body temperature on brain edema and encephalopathy in the rat after hepatic devascularization.  Gastroenterology . 1989;  96 885-891
  PubMedGoogle Scholar
• 70 Rose C, Michalak A, Pannunzio M. et al . Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure.  Hepatology . 2000;  31 872-877
  CrossrefPubMedGoogle Scholar
• 71 Jalan R, Olde Damink W M S, Deutz N EP. et al . Treatment of uncontrolled intracranial hypertension in acute liver failure with moderate hypothermia.  Lancet . 1999;  354 1164-1168
  CrossrefPubMedGoogle Scholar
• 72 Jalan R, Olde Damink W S, Deutz N E. et al . Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia.  Hepatology . 2001;  34 50-54
  CrossrefPubMedGoogle Scholar
• 73 Jalan R, Olde Damink W M S, Deutz N EP. et al . Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure.  Transplantation . 2003;  75 2034-2039
  CrossrefPubMedGoogle Scholar